Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Rue Auguste Piccard 48, Gosselies,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://aboleris-pharma.com
- HQ
- Gosselies
Aboleris Pharma Questions
Aboleris Pharma's website is http://aboleris-pharma.com
Aboleris Pharma's LinkedIn profile is https://be.linkedin.com/company/aboleris-pharma
Aboleris Pharma has
13 employees.
View email and phone details for 13
employees at Aboleris Pharma.
Aboleris Pharma's industry is
Biotechnology Research
Aboleris Pharma's top competitors are
Quidditas,
Remynd,
Quantoom Biosciences,
Azalea Vision,
Ciloa Sas,
Signatur Biosciences,
Gynaia,
Epics Therapeutics,
Edelris,
Santero Therapeutics.
Aboleris Pharma's categories are Biotechnology Research
Aboleris Pharma's founding year is 2019
